FOR months, Gary Buesnel was back and forth to see doctors, complaining of stomach aches and pains. Yet repeatedly, medics ...

It was pancreatic cancer - one of the UK ... “He had to go to the UK to have a stent put in because his bile duct was blocked, but because it was the start of Covid, he had to isolate for ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments. The work is published in the ...

J Gastroenterol Hepatol. 2009;24(7):1198-1202. A fistulous communication arising from the duct could not be demonstrated in nearly one third of our patients. It could be argued that the fistulas ...

MSD’s PD-1 inhibitor Keytruda has been approved by the FDA as a treatment for locally advanced unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy, the first ...

CA 19–9, the only serum biomarker currently available in routine clinical practice for the diagnosis of biliary and pancreatic cancers ... for the discovery of new cancer biomarkers.

Department of Gastroenterology, St. Bartholomew's Hospital, London. Palliative treatment is appropriate for most patients with cancer of the head of pancreas. Insertion of a biliary stent relieves ...

This will help promote further research in the treatment of PFCs. Lumen-apposing metal stents (LAMS) are increasingly used for treatment of pancreatic fluid collections (PFC); some reports have ...

Pancreatic cancer is a significant cause of cancer-related mortality and often presents with limited treatment options. Pancreatic tumors are also notorious for their immunosuppressive ...

Background: Advanced biliary tract cancer (BTC) has a poor prognosis. Gemcitabine with platinum chemotherapy was the standard first-line chemotherapeutic regimen until the recent addition of anti-PD-1 ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.